Proverjim S de RL Mi
FDA import alert and refusal historyQuecholac, MexicoFEI 3026170483
Recorded by FDA as PROVERJIM S DE RL MI
As of October 26, 2026, Proverjim S de RL Mi is on the green list of FDA Import Alert 24-23, which exempts its listed products from detention without physical examination under that alert, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 24-23 · green list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- Classified NAI (No Action Indicated)
Every FDA record for Proverjim S de RL Mi
2 records, newest first. Each line links to the FDA page it came from.
2025
- InspectionInspection classified NAI (No Action Indicated)Foodborne Biological HazardsSource
2024
- Import alert listingListed on Import Alert 24-23green listCilantroSource
Questions about Proverjim S de RL Mi
- Is Proverjim S de RL Mi on an FDA import alert?
- Yes. As of October 26, 2026, Proverjim S de RL Mi is on the green list of FDA Import Alert 24-23, “Fresh cilantro from Puebla, Mexico (seasonal)”, for cilantro; FDA published the listing on May 31, 2024.
- Has FDA refused shipments from Proverjim S de RL Mi?
- No FDA import refusals for Proverjim S de RL Mi appear in FDA's refusal data since October 2016, as of October 26, 2026.
- When was Proverjim S de RL Mi last inspected by FDA?
- FDA's most recent inspection of Proverjim S de RL Mi with a final classification is dated September 2, 2025 and was classified NAI (No Action Indicated).
- What is Proverjim S de RL Mi's FEI number?
- Proverjim S de RL Mi's FDA Establishment Identifier (FEI) is 3026170483.
Buying from Proverjim S de RL Mi?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.